文献速递哮喘呼吸道感染

哮喘为何可能意外防止COVID-19不良结局

Why asthma might surprisingly protect against poor outcomes in COVID-19.
PubMed 文献 · Eur Respir J · 2020-12-10

本文针对Beurnier等的研究进行评论,该研究报告768例COVID-19住院患者中哮喘患病率较低(4.8%),且哮喘亚组无一例出现哮喘急性加重,仅一例接受支气管痉挛治疗,死亡率较无哮喘对照组显著降低。作者认为这些发现因样本量小、单中心及对照组年龄和性别差异而属初步,可能为统计假象。

要点

  • 哮喘患者COVID-19住院率较低(4.8%),且未见哮喘急性加重。
  • 哮喘亚组死亡率显著低于无哮喘对照组。
  • 结论需谨慎,因样本小、单中心且对照组年龄性别不均衡。

核心结论

  • 哮喘可能通过改变病毒进入受体表达、吸入糖皮质激素使用、慢性炎症、防护减少暴露或黏液高分泌等机制防止COVID-19不良结局。
  • 现有发现需视为初步,不能排除统计假象。

研究设计与样本

  • 评论文章,针对Beurnier等的一项单中心队列研究(768例COVID-19住院患者)进行讨论。

主要发现

  • 住院COVID-19患者中哮喘患病率为4.8%,低于一般人群。
  • 哮喘亚组无一例出现哮喘急性加重,仅一例接受支气管痉挛治疗。
  • 哮喘亚组死亡率较无哮喘对照组显著降低。

临床怎么用

  • 临床应谨慎解读哮喘对COVID-19结局的保护性关联,避免据此改变哮喘管理。
  • 需更大规模、多中心研究验证。

局限性

  • 样本量相对较小,单中心设计。
  • 对照组年龄更大、男性比例更高,均与更差结局相关,可能导致统计假象。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asthma may protect against poor outcomes in COVID-19 due to several possible mechanisms, including altered viral entry receptor expression, inhaled corticosteroid use, chronic inflammation, reduced exposure due to shielding and/or mucus hypersecretion https://bit.ly/3eiXOPP We read with interest the study by Beurnier et al. [1] describing a lower prevalence of asthma (4.8%) in a cohort of 768 patients hospitalised with coronavirus disease 2019 (COVID-19) compared to the general population, none of whom presented with an asthma exacerbation and only one who was treated for bronchospasm. This subgroup also had significantly reduced mortality compared to a control group without asthma. These findings must be considered preliminary given that they arise from a relatively small, single-centre cohort. In particular, the control group differed significantly in age (older) and gender balance (greater male/female ratio); both characteristics are associated worse outcomes and this raises the possibility that the results represent a statistical artefact.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Farne H, Singanayagam A. Why asthma might surprisingly protect against poor outcomes in COVID-19. Eur Respir J. 2020. PMID: 33154034. doi:10.1183/13993003.03045-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。